Sunil J Ghelani, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fontan Procedure | 14 | 2024 | 805 | 4.230 |
Why?
|
Heart Defects, Congenital | 16 | 2024 | 4712 | 2.230 |
Why?
|
Heart Ventricles | 14 | 2024 | 3831 | 1.600 |
Why?
|
Myocardial Contraction | 5 | 2024 | 1516 | 1.150 |
Why?
|
Magnetic Resonance Imaging, Cine | 5 | 2024 | 1089 | 1.050 |
Why?
|
Tetralogy of Fallot | 4 | 2024 | 628 | 1.010 |
Why?
|
Ventricular Dysfunction, Left | 7 | 2024 | 2143 | 0.890 |
Why?
|
Predictive Value of Tests | 13 | 2024 | 15425 | 0.860 |
Why?
|
Sinus of Valsalva | 1 | 2023 | 60 | 0.860 |
Why?
|
Ventricular Function, Left | 6 | 2024 | 3934 | 0.850 |
Why?
|
Coronary Sinus | 1 | 2023 | 85 | 0.830 |
Why?
|
Stomach | 2 | 2023 | 701 | 0.770 |
Why?
|
Heart Aneurysm | 1 | 2021 | 114 | 0.750 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 3 | 2012 | 538 | 0.730 |
Why?
|
Echocardiography | 8 | 2020 | 5038 | 0.710 |
Why?
|
Cardiac Volume | 2 | 2018 | 196 | 0.700 |
Why?
|
Myocarditis | 2 | 2021 | 802 | 0.680 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2021 | 235 | 0.640 |
Why?
|
Aortic Aneurysm | 1 | 2023 | 649 | 0.620 |
Why?
|
Echocardiography, Three-Dimensional | 3 | 2018 | 611 | 0.600 |
Why?
|
Electrocardiography | 5 | 2024 | 6408 | 0.590 |
Why?
|
Atrial Function, Left | 1 | 2017 | 188 | 0.530 |
Why?
|
Cardiovascular Agents | 2 | 2012 | 849 | 0.520 |
Why?
|
Ventricular Function, Right | 2 | 2023 | 629 | 0.490 |
Why?
|
Heart Transplantation | 4 | 2024 | 3306 | 0.490 |
Why?
|
Artifacts | 1 | 2023 | 1897 | 0.480 |
Why?
|
Ventricular Septum | 3 | 2023 | 76 | 0.460 |
Why?
|
Ventricular Function | 1 | 2016 | 403 | 0.460 |
Why?
|
Stroke Volume | 5 | 2022 | 5618 | 0.440 |
Why?
|
Thoracic Duct | 2 | 2024 | 71 | 0.430 |
Why?
|
Pulmonary Artery | 4 | 2024 | 1938 | 0.400 |
Why?
|
Mitral Valve | 5 | 2024 | 1473 | 0.390 |
Why?
|
Arteriovenous Fistula | 1 | 2015 | 320 | 0.390 |
Why?
|
Ventricular Remodeling | 2 | 2023 | 1281 | 0.390 |
Why?
|
Heart Atria | 1 | 2017 | 1362 | 0.380 |
Why?
|
Child | 34 | 2024 | 80670 | 0.370 |
Why?
|
Retrospective Studies | 32 | 2024 | 81657 | 0.370 |
Why?
|
Child, Preschool | 24 | 2024 | 42577 | 0.360 |
Why?
|
Heart | 5 | 2024 | 4425 | 0.360 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 519 | 0.350 |
Why?
|
Pulmonary Atresia | 2 | 2023 | 159 | 0.340 |
Why?
|
Adolescent | 25 | 2024 | 88902 | 0.340 |
Why?
|
Pulmonary Veins | 1 | 2015 | 759 | 0.320 |
Why?
|
Pulmonary Valve | 2 | 2023 | 413 | 0.310 |
Why?
|
Young Adult | 18 | 2024 | 59939 | 0.300 |
Why?
|
Benchmarking | 1 | 2014 | 1056 | 0.290 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2024 | 595 | 0.290 |
Why?
|
Ultrasonography, Prenatal | 1 | 2015 | 1772 | 0.280 |
Why?
|
Radiography, Interventional | 1 | 2014 | 1129 | 0.280 |
Why?
|
Phenotype | 1 | 2024 | 16722 | 0.260 |
Why?
|
Radiation Dosage | 1 | 2014 | 1958 | 0.250 |
Why?
|
Pulmonary Circulation | 2 | 2018 | 744 | 0.250 |
Why?
|
Risk Assessment | 6 | 2024 | 24299 | 0.240 |
Why?
|
Tricuspid Valve | 3 | 2023 | 419 | 0.240 |
Why?
|
Coronary Vessels | 3 | 2021 | 3115 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 10 | 2024 | 36570 | 0.230 |
Why?
|
Infant | 16 | 2024 | 36459 | 0.220 |
Why?
|
Mitral Valve Insufficiency | 4 | 2024 | 1414 | 0.220 |
Why?
|
Humans | 54 | 2024 | 766812 | 0.220 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2024 | 3360 | 0.220 |
Why?
|
Cardiac Surgical Procedures | 3 | 2024 | 3683 | 0.210 |
Why?
|
Weight Gain | 1 | 2012 | 2356 | 0.200 |
Why?
|
Male | 33 | 2024 | 364154 | 0.190 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2023 | 216 | 0.190 |
Why?
|
Heart-Assist Devices | 1 | 2012 | 1287 | 0.190 |
Why?
|
Milrinone | 1 | 2021 | 86 | 0.190 |
Why?
|
Giant Cells | 1 | 2021 | 187 | 0.190 |
Why?
|
Female | 34 | 2024 | 396532 | 0.190 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2012 | 1481 | 0.180 |
Why?
|
Glomerular Filtration Rate | 2 | 2022 | 2232 | 0.180 |
Why?
|
Heart Failure | 2 | 2022 | 11879 | 0.180 |
Why?
|
Time Factors | 7 | 2024 | 40149 | 0.170 |
Why?
|
Arrhythmias, Cardiac | 1 | 2009 | 2257 | 0.170 |
Why?
|
Mitral Valve Prolapse | 1 | 2021 | 213 | 0.170 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2021 | 140 | 0.160 |
Why?
|
Ureter | 1 | 2022 | 364 | 0.160 |
Why?
|
Williams Syndrome | 1 | 2021 | 195 | 0.150 |
Why?
|
Cardiotonic Agents | 1 | 2021 | 541 | 0.150 |
Why?
|
Models, Cardiovascular | 1 | 2024 | 978 | 0.150 |
Why?
|
Observer Variation | 4 | 2020 | 2614 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2024 | 643 | 0.150 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2021 | 262 | 0.150 |
Why?
|
Practice Guidelines as Topic | 2 | 2014 | 7430 | 0.150 |
Why?
|
Risk Factors | 10 | 2024 | 74889 | 0.150 |
Why?
|
Heart Neoplasms | 1 | 2021 | 374 | 0.150 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2018 | 164 | 0.150 |
Why?
|
Imaging, Three-Dimensional | 2 | 2024 | 4047 | 0.140 |
Why?
|
Gastric Emptying | 1 | 2020 | 247 | 0.140 |
Why?
|
Abdomen | 1 | 2023 | 1137 | 0.140 |
Why?
|
Pacemaker, Artificial | 1 | 2023 | 828 | 0.140 |
Why?
|
Cluster Analysis | 1 | 2024 | 2721 | 0.140 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2021 | 361 | 0.140 |
Why?
|
Milk | 1 | 2020 | 436 | 0.140 |
Why?
|
Infant, Newborn | 8 | 2023 | 26387 | 0.140 |
Why?
|
Troponin T | 1 | 2022 | 786 | 0.140 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4424 | 0.130 |
Why?
|
Reference Values | 3 | 2019 | 4914 | 0.130 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2018 | 145 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2023 | 3681 | 0.130 |
Why?
|
Collateral Circulation | 1 | 2017 | 289 | 0.130 |
Why?
|
Marfan Syndrome | 1 | 2018 | 237 | 0.130 |
Why?
|
Creatinine | 1 | 2022 | 1917 | 0.130 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3431 | 0.130 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26309 | 0.120 |
Why?
|
Adult | 12 | 2024 | 223305 | 0.120 |
Why?
|
Robotics | 1 | 2021 | 807 | 0.120 |
Why?
|
Reproducibility of Results | 9 | 2020 | 20146 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1884 | 0.120 |
Why?
|
Treatment Outcome | 8 | 2024 | 65286 | 0.110 |
Why?
|
Coronary Vessel Anomalies | 1 | 2017 | 308 | 0.110 |
Why?
|
Exercise Test | 2 | 2018 | 2188 | 0.110 |
Why?
|
Exercise Tolerance | 1 | 2018 | 845 | 0.110 |
Why?
|
Vena Cava, Superior | 2 | 2024 | 197 | 0.110 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2023 | 1564 | 0.100 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2022 | 1750 | 0.100 |
Why?
|
Postoperative Complications | 1 | 2015 | 15831 | 0.100 |
Why?
|
Biliary Atresia | 1 | 2013 | 88 | 0.100 |
Why?
|
Boston | 2 | 2016 | 9346 | 0.100 |
Why?
|
Muscular Dystrophies | 1 | 2015 | 393 | 0.100 |
Why?
|
India | 2 | 2009 | 2335 | 0.100 |
Why?
|
Phenobarbital | 1 | 2013 | 192 | 0.100 |
Why?
|
Linear Models | 2 | 2012 | 5873 | 0.100 |
Why?
|
Sensitivity and Specificity | 4 | 2022 | 14653 | 0.100 |
Why?
|
Age Factors | 4 | 2020 | 18397 | 0.090 |
Why?
|
Aging | 3 | 2024 | 8728 | 0.090 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1674 | 0.090 |
Why?
|
Vena Cava, Inferior | 2 | 2024 | 463 | 0.090 |
Why?
|
Coronary Circulation | 1 | 2017 | 1602 | 0.090 |
Why?
|
Age Distribution | 2 | 2017 | 2869 | 0.090 |
Why?
|
Postoperative Period | 1 | 2015 | 1824 | 0.090 |
Why?
|
Myocardium | 1 | 2023 | 4765 | 0.090 |
Why?
|
Cholestasis | 1 | 2013 | 385 | 0.080 |
Why?
|
Peptide Fragments | 1 | 2022 | 5143 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12064 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39312 | 0.080 |
Why?
|
Contrast Media | 1 | 2021 | 5329 | 0.070 |
Why?
|
Infant Mortality | 1 | 2012 | 751 | 0.070 |
Why?
|
Brachial Artery | 1 | 2009 | 373 | 0.070 |
Why?
|
Radiation Injuries | 1 | 2014 | 1195 | 0.070 |
Why?
|
American Heart Association | 1 | 2012 | 1049 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2846 | 0.070 |
Why?
|
Image Enhancement | 2 | 2015 | 2858 | 0.070 |
Why?
|
Swine | 3 | 2021 | 5985 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4252 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2016 | 2101 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3563 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2017 | 4525 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6853 | 0.060 |
Why?
|
United States | 4 | 2014 | 72945 | 0.060 |
Why?
|
Birth Weight | 1 | 2012 | 2123 | 0.060 |
Why?
|
Hemodynamics | 2 | 2024 | 4188 | 0.050 |
Why?
|
Pregnancy | 2 | 2015 | 30236 | 0.050 |
Why?
|
Indomethacin | 1 | 2023 | 323 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2015 | 2058 | 0.050 |
Why?
|
Radionuclide Imaging | 2 | 2020 | 1986 | 0.050 |
Why?
|
Hospitals, Pediatric | 1 | 2012 | 1851 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6306 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2012 | 2116 | 0.050 |
Why?
|
Recovery of Function | 1 | 2012 | 2978 | 0.050 |
Why?
|
Ibuprofen | 1 | 2023 | 228 | 0.050 |
Why?
|
Acute Disease | 1 | 2012 | 7240 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12826 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2022 | 527 | 0.040 |
Why?
|
Biopsy | 1 | 2012 | 6779 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9661 | 0.040 |
Why?
|
Algorithms | 2 | 2024 | 14073 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1104 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10101 | 0.040 |
Why?
|
Watchful Waiting | 1 | 2023 | 492 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 41706 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1733 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2023 | 870 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2024 | 856 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12536 | 0.040 |
Why?
|
Logistic Models | 1 | 2012 | 13276 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2021 | 5306 | 0.040 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2016 | 67 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2012 | 3411 | 0.030 |
Why?
|
Gadolinium | 1 | 2021 | 964 | 0.030 |
Why?
|
Registries | 1 | 2012 | 8352 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2078 | 0.030 |
Why?
|
Ultrasonography | 1 | 2009 | 5990 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2120 | 0.030 |
Why?
|
Incidence | 1 | 2012 | 21527 | 0.030 |
Why?
|
District of Columbia | 1 | 2013 | 159 | 0.030 |
Why?
|
Reoperation | 1 | 2023 | 4325 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1874 | 0.020 |
Why?
|
Equipment Design | 1 | 2018 | 3488 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2662 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7571 | 0.020 |
Why?
|
Animals | 4 | 2021 | 168939 | 0.020 |
Why?
|
Prevalence | 2 | 2016 | 15835 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22350 | 0.020 |
Why?
|
Causality | 1 | 2013 | 1252 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10384 | 0.020 |
Why?
|
Software | 1 | 2020 | 4464 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12985 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13642 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22248 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15912 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14762 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54872 | 0.010 |
Why?
|
Middle Aged | 1 | 2024 | 223267 | 0.010 |
Why?
|